Name: GLORIA
A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High Risk, Early Stage Globo H-Positive Triple Negative Breast Cancer.
Principal Investigator: Dr Susan Tiley
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Breast Cancer
More information about GLORIA study
Radiation Oncology clinical trials
Name: EXPERT
A randomised phase III trial of adjuvant radiation therapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised luminal A early breast cancer (EXPERT)
Principal Investigator: Dr Hester Lieng
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Breast Cancer
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials